Clinical trial
The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer…
NCT00292279 · Sino-Swed Pharmaceutical Corporation, Industry · Completed
Key facts
| NCT number | NCT00292279 |
|---|---|
| Title | The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients |
| Official title | The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients: A Randomized, Double Blind, Controlled, Multi-Center Clinical Trial. |
| Lead sponsor | Sino-Swed Pharmaceutical Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carcinoma Surgery, Parenteral Nutrition, Post-Operative Hospital Stay |
| Intervention type | Drug |
| Interventions | Omega-3 fish oil emulsion (Omegaven ), long-chain triglyceride |
| Enrollment | 206 |
| Start date | Jun 1, 2002 |
| Primary completion | Nov 1, 2003 |
| Completion | Feb 1, 2004 |
| First posted | Feb 15, 2006 |
| Last update posted | May 14, 2008 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: